STOCK TITAN

Intra-Cellular Therapies to Host First Quarter 2021 Financial Results Conference Call and Webcast

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI) announced a conference call on May 10, 2021, at 8:30 a.m. ET to discuss its financial results for Q1 2021. The call will provide a corporate update and detailed financials for the quarter ended March 31, 2021. Investors can access the call via phone or through a live and archived webcast on the company's website. Intra-Cellular Therapies develops therapeutics for CNS disorders based on innovative intracellular research.

Positive
  • Upcoming conference call to discuss Q1 2021 financial results, providing investors insight into company performance.
Negative
  • None.

NEW YORK, May 04, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Monday, May 10, 2021, to provide a corporate update and discuss details of the Company's financial results for the quarter ended March 31, 2021.

To access the live conference call via phone, dial 1-(844) 835-6563. The international dial-in number is 1-(970) 315-3916. The conference ID number for the live call is 3244409.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D. 
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

Source: Intra-Cellular Therapies Inc.


FAQ

When is Intra-Cellular Therapies' next conference call?

The next conference call is scheduled for May 10, 2021, at 8:30 a.m. ET.

What will be discussed in the upcoming conference call for ITCI?

The conference call will cover a corporate update and the financial results for the quarter ended March 31, 2021.

How can I access the ITCI conference call?

You can access the conference call via phone or through a live and archived webcast on the company's website.

Intra-Cellular Therapies Inc.

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

9.08B
101.92M
2.33%
96.02%
2.23%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BEDMINSTER